Raloxifene hydrochloride hydrate

Raloxifene Hydrochloride Hydrate is a pharmaceutical-grade active ingredient used in the manufacture of medications for postmenopausal women. It is a Selective Estrogen Receptor Modulator (SERM) that mimics estrogen’s beneficial effects on bone while blocking estrogen’s effects in breast tissue. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include raloxifene hydrochloride monohydrate and Raloxifene hydrochloride hydrate [JAN]. Its PubChem CID is 24772103.

CAS No 1020061-04-4
Molecular Formula C28H30ClNO5S
Molecular Weight 528.1 g/mol
Synonyms [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrate;hydrochloride

Frequently Asked Questions